Meanwhile, ectopically expressing miR-500 rendered gastric cancer cells more resistant to treatment by the chemotherapeutic agent cisplatin, as indicated by the TUNEL and annexin V assays (Figure 2E and Supplementary Figure 1). This evidence concerns the gene ANXA5 and gastric cancer.